| 7/21/2021 |
Goldman Sachs Group Inc. Raises Holdings in NeoGenomics, Inc. (NASDAQ:NEO) |
The Markets Daily |
... according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 293,616 shares of the medical research company’s stock after purchasing an additional 95,696 shares during the period. Goldman Sachs Group Inc. owned about 0.25% of NeoGenomics worth $14,161,000 at the end of the most recent reporting period. Other institutional investors also recently made changes to their positions in the company. Rhumbline Advisers increased ... |
| 7/21/2021 |
Goldman Sachs Group Inc. Raises Stock Position in NeoGenomics, Inc. (NASDAQ:NEO) |
Dakota Financial News |
... the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 293,616 shares of the medical research company’s stock after buying an additional 95,696 shares during the period. Goldman Sachs Group Inc.’s holdings in NeoGenomics were worth $14,161,000 at the end of the most recent reporting period. Other hedge funds and other institutional investors have also made changes to their positions in the ... |
| 7/21/2021 |
Comprehensive Study on Capital Restructuring Services Market 2021 with Top Leading Vendors like|KPMG International Cooperative, PwC |
PRSync |
... end-use segments, SWOT analysis, and segments such as different geography evolving. In the general version of this study, some of the profiled players are KPMG International Cooperative, PwC, Deloitte Touche Tohmatsu Limited, The Goldman Sachs Group, Inc, Ernst & Young Global Limited, Accenture Plc, McKinsey & Company, Boston Consulting Group, Capgemini SE, The Goldman Sachs Group, Inc, Ernst & Young Global Limited, HSBC Holdings Plc. REQUEST to GET FREE Sample PDF of ... |
| 7/20/2021 |
Why the Markets Worry About the Delta Variant |
dnyuz.com |
The market is not immune to the Delta variant Last week, analysts at Goldman Sachs told clients that the potential economic impact of the Delta variant of the coronavirus would be “modest.” Even if that turns out to be the case, investors look nervous as infections spread because of the highly contagious strain.Yesterday, the S&P 500 recorded its steepest one-day drop since May and European stocks ... |
| 7/20/2021 |
SVB Leerink Research Analysts Decrease Earnings Estimates for Moderna, Inc. (NASDAQ:MRNA) - Transcript Daily |
transcriptdaily.com |
... Get Moderna alerts: Other equities analysts have also recently issued reports about the company. Needham & Company LLC restated a “hold” rating on shares of Moderna in a report on Friday, April 16th. The Goldman Sachs Group increased their price objective on shares of Moderna from $206.00 to $228.00 and gave the company a “buy” rating in a research report on Friday, May 7th. Argus increased their price objective ... |
| 7/20/2021 |
Cadence Bancorporation (CADE) to Release Quarterly Earnings on Thursday | Daily Political |
Daily Political |
... to $453.00 in a research note published on Friday, PriceTargets.com reports. The firm currently has an overweight rating on the biotechnology company’s stock.Several other research analysts have also commented on BIIB. The Goldman Sachs Group raised their price target on Biogen from $246.00 to $436.00 and gave the stock a neutral rating in a research report on Monday, June 14th. Royal Bank of Canada cut their price target ... |
| 7/20/2021 |
ZoomInfo Technologies (NASDAQ:ZI) Upgraded to Hold by Zacks Investment Research |
thelincolnianonline.com |
... have also weighed in on the company. Stifel Nicolaus started coverage on ZoomInfo Technologies in a research report on Friday. They issued a buy rating and a $65.00 price target for the company. The Goldman Sachs Group initiated coverage on shares of ZoomInfo Technologies in a report on Monday, March 22nd. They issued a buy rating and a $65.00 target price for the company. Wolfe Research initiated coverage on shares ... |
| 7/20/2021 |
Critical Comparison: PowerFleet (NASDAQ:PWFL) versus ALR Technologies (OTCMKTS:ALRT) | Daily Political |
Daily Political |
... equities analysts also recently commented on the stock. William Blair initiated coverage on shares of Alignment Healthcare in a research note on Tuesday, April 20th. They issued an outperform rating on the stock. The Goldman Sachs Group began coverage on shares of Alignment Healthcare in a report on Tuesday, April 20th. They set a neutral rating and a $25.00 price target for the company. UBS Group began coverage on shares ... |
| 7/20/2021 |
Beacon Pointe Advisors LLC Invests $216,000 in Conagra Brands, Inc. (NYSE:CAG) - WKRB News |
wkrb13.com |
... raised its stake in Conagra Brands by 1,557.6% during the first quarter. Strs Ohio now owns 90,457 shares of the company’s stock worth $3,401,000 after purchasing an additional 85,000 shares during the period. Goldman Sachs Group Inc. raised its stake in Conagra Brands by 8.0% during the first quarter. Goldman Sachs Group Inc. now owns 2,136,561 shares of the company’s stock worth $80,334,000 after purchasing an additional 157,619 ... |
| 7/20/2021 |
California State Teachers Retirement System Increases Stock Holdings in Conagra Brands, Inc. (NYSE:CAG) |
com-unik.info |
... shares of Conagra Brands by 1,557.6% during the first quarter. Strs Ohio now owns 90,457 shares of the company’s stock valued at $3,401,000 after buying an additional 85,000 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Conagra Brands by 8.0% during the first quarter. Goldman Sachs Group Inc. now owns 2,136,561 shares of the company’s stock valued at $80,334,000 after buying ... |
| 7/20/2021 |
Thermo Fisher Scientific (NYSE:TMO) Coverage Initiated at Benchmark - Watch List News |
watchlistnews.com |
... Analyst Price Targets reports. The firm issued a buy rating and a $580.00 target price on the medical research company’s stock.Several other research firms have also recently issued reports on TMO. The Goldman Sachs Group decreased their price objective on Thermo Fisher Scientific from $590.00 to $530.00 and set a buy rating on the stock in a report on Tuesday, June 15th. They noted that the move was ... |
| 7/20/2021 |
Short Interest in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Rises By 36.9% - Mayfield Recorder |
Mayfield Recorder |
... on shares of ACADIA Pharmaceuticals from $33.00 to $45.00 and gave the stock an “overweight” rating in a report on Tuesday, April 6th. They noted that the move was a valuation call. The Goldman Sachs Group reissued a “neutral” rating and set a $25.00 price objective (down from $73.00) on shares of ACADIA Pharmaceuticals in a report on Tuesday, April 13th. Morgan Stanley boosted their price objective on ... |
| 7/20/2021 |
Bright Health Group (NYSE:BHG) Coverage Initiated by Analysts at Citigroup |
Mayfield Recorder |
... on Monday morning, Analyst Ratings Network reports. The brokerage issued a neutral rating and a $16.00 target price on the stock. A number of other research firms have also weighed in on BHG. The Goldman Sachs Group started coverage on Bright Health Group in a research note on Monday. They set a buy rating for the company. Royal Bank of Canada started coverage on Bright Health Group in a research ... |
| 7/20/2021 |
Alignment Healthcare (NASDAQ:ALHC) Upgraded to “Hold” by Zacks Investment Research |
zolmax.com |
... objective for the company. Bank of America started coverage on Alignment Healthcare in a report on Tuesday, April 20th. They issued a neutral rating and a $29.00 price objective for the company. Finally, The Goldman Sachs Group started coverage on Alignment Healthcare in a report on Tuesday, April 20th. They set a neutral rating and a $25.00 price target for the company. Four equities research analysts have rated the stock ... |
| 7/19/2021 |
7,829,547 Shares in Alignment Healthcare, Inc. (NASDAQ:ALHC) Acquired by Price T Rowe Associates Inc. MD |
thelincolnianonline.com |
... Management LP bought a new position in Alignment Healthcare in the 1st quarter valued at $4,386,000. HRT Financial LP bought a new position in Alignment Healthcare in the 1st quarter valued at $1,289,000. Finally, Goldman Sachs Group Inc. bought a new position in Alignment Healthcare in the 1st quarter valued at $27,444,000. 77.53% of the stock is owned by institutional investors. ALHC has been the subject of several analyst reports ... |
| 7/19/2021 |
1,150,391 Shares in Signify Health, Inc. (NYSE:SGFY) Bought by Janus Henderson Group PLC - Ticker Report |
Ticker Report |
... acquired a new position in shares of Signify Health in the 1st quarter worth $2,690,000. Centiva Capital LP acquired a new stake in shares of Signify Health in the first quarter worth $565,000. Finally, Goldman Sachs Group Inc. acquired a new stake in shares of Signify Health in the first quarter worth $704,000.Get Signify Health alerts: Several brokerages have recently commented on SGFY. Robert W. Baird began coverage on ... |
| 7/18/2021 |
NeoGenomics, Inc. (NASDAQ:NEO) Forecasted to Post Q2 2021 Earnings of ($0.10) Per Share |
slatersentinel.com |
... Äù rating and a $55.00 price objective for the company. Zacks Investment Research lowered NeoGenomics from a ‚Äúhold‚Äù rating to a ‚Äúsell‚Äù rating in a report on Wednesday, April 28th. Finally, The Goldman Sachs Group initiated coverage on NeoGenomics in a research note on Thursday, June 3rd. They set a ‚Äúbuy‚Äù rating and a $55.00 price objective on the stock. One investment analyst has rated the stock ... |
| 7/18/2021 |
Nuveen Asset Management LLC Buys 104,285 Shares of NeoGenomics, Inc. (NASDAQ:NEO) |
com-unik.info |
... by 4.5% during the 1st quarter. Thrivent Financial for Lutherans now owns 96,062 shares of the medical research company’s stock valued at $4,633,000 after acquiring an additional 4,160 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in shares of NeoGenomics by 48.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 293,616 shares of the medical research company’s stock valued at $14,161,000 after ... |
| 7/17/2021 |
NeoGenomics, Inc. (NASDAQ:NEO) Forecasted to Post Q2 2021 Earnings of ($0.10) Per Share - Ticker Report |
Ticker Report |
... alerts: Several other research analysts have also weighed in on NEO. Zacks Investment Research lowered NeoGenomics from a “hold” rating to a “sell” rating in a report on Wednesday, April 28th. The Goldman Sachs Group began coverage on NeoGenomics in a report on Thursday, June 3rd. They set a “buy” rating and a $55.00 price objective on the stock. Finally, Needham & Company LLC initiated coverage on NeoGenomics ... |
| 7/16/2021 |
Covid: Goldman cuts Southeast Asia GDP forecasts as delta variant spreads |
CNBC |
... an Islamic junior high school in Banda Aceh on June 10, 2020. Chaideer Mahyuddin AFP Getty Images SINGAPORE — Covid-19 infections are surging in several major Southeast Asian economies, and that has led Goldman Sachs to cut its 2021 growth forecasts for most of the region.The spread of the more transmissible delta variant has pushed daily Covid cases to record highs in Indonesia , Malaysia and Thailand in recent ... |